Topic: Avandia
GlaxoSmithKline's controversial diabetes pill Avandia should be pulled from the U.K. market because of concerns that the drug can increase the risk of heart attacks, British drug regulators said Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) said an independent panel ...
CHICAGO (Reuters) - GlaxoSmithKline's diabetes drug Avandia was no riskier to the heart than a rival, U.S. researchers said on Tuesday, a finding that contradicts earlier studies and adds new fodder to the roiling debate over the drug's safety. The study of ...
CHICAGO (Reuters) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, U.S. researchers said on Wednesday. The researchers had believed Avandia and Takeda Pharmaceutical Co's Actos work by ...
FDA bars new patients from enrolling in safety study of diabetes drug tied to heart risksFederal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases ...
A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of ...
Diabetes drug Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems. The committee, convened at the request of the Food and Drug ...
British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who ...
UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting ...
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food ...
British pharmaceutical giant GlaxoSmithKline withheld from US drug safety regulators information about the possible dangers of top-selling diabetes drug Avandia, a report in the US press said Tuesday. The allegation was made in the Wall Street Journal on the day that Food ...
Photo Gallery
From Around the Web
Video Gallery
-
UK wants to stop GSK's ...
British drug regulators call for GlaxoSmithKline's diabetes drug Avandia ...2010-09-06 -
Avandia (Rosiglitazone) increases risk Heart Attac...
Clip thanks to www.healthstride.net A new study led ...2010-09-02 -
Avandia
Avandia For more information, visit www.MedicineCoach.com2008-03-23
